Literature DB >> 32061320

The ubiquitin proteasome system and schizophrenia.

Sandra Luza1, Carlos M Opazo1, Chad A Bousman2, Christos Pantelis3, Ashley I Bush4, Ian P Everall5.   

Abstract

The ubiquitin-proteasome system is a master regulator of neural development and the maintenance of brain structure and function. It influences neurogenesis, synaptogenesis, and neurotransmission by determining the localisation, interaction, and turnover of scaffolding, presynaptic, and postsynaptic proteins. Moreover, ubiquitin-proteasome system signalling transduces epigenetic changes in neurons independently of protein degradation and, as such, dysfunction of components and substrates of this system has been linked to a broad range of brain conditions. Although links between ubiquitin-proteasome system dysfunction and neurodegenerative disorders have been known for some time, only recently have similar links emerged for neurodevelopmental disorders, such as schizophrenia. Here, we review the components of the ubiquitin-proteasome system that are reported to be dysregulated in schizophrenia, and discuss specific molecular changes to these components that might, in part, explain the complex causes of this mental disorder.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 32061320     DOI: 10.1016/S2215-0366(19)30520-6

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN: 2215-0366            Impact factor:   27.083


  15 in total

Review 1.  Exploring the Role of Ubiquitin-Proteasome System in Parkinson's Disease.

Authors:  Tapan Behl; Sachin Kumar; Ziyad M Althafar; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Vishnu Nayak Badavath; Shivam Yadav; Saurabh Bhatia; Ahmed Al-Harrasi; Yosif Almoshari; Mohannad A Almikhlafi; Simona Bungau
Journal:  Mol Neurobiol       Date:  2022-05-03       Impact factor: 5.590

2.  [Effects of ring finger and tryptophan-aspartic acid 2 on dendritic spines and synapse formation in cerebral cortex neurons of mice].

Authors:  T Sun; Y Wang; Z Fang; J Xu; S Ma; J Chang; G Liu; Y Guo; C Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-01-20

3.  PTMs: A Missing Piece for Schizophrenia Studies.

Authors:  Caroline Brandão-Teles; Bradley J Smith; Victor Corasolla Carregari
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Convergent and distributed effects of the 3q29 deletion on the human neural transcriptome.

Authors:  Esra Sefik; Ryan H Purcell; Elaine F Walker; Gary J Bassell; Jennifer G Mulle
Journal:  Transl Psychiatry       Date:  2021-06-15       Impact factor: 6.222

5.  The Antipsychotic Drug Clozapine Suppresses the RGS4 Polyubiquitylation and Proteasomal Degradation Mediated by the Arg/N-Degron Pathway.

Authors:  Jun Hyoung Jeon; Tae Rim Oh; Seoyoung Park; Sunghoo Huh; Ji Hyeon Kim; Binh Khanh Mai; Jung Hoon Lee; Se Hyun Kim; Min Jae Lee
Journal:  Neurotherapeutics       Date:  2021-04-21       Impact factor: 6.088

6.  Polygenic risk for mental disorder reveals distinct association profiles across social behaviour in the general population.

Authors:  Fenja Schlag; Andrea G Allegrini; Jan Buitelaar; Ellen Verhoef; Marjolein van Donkelaar; Robert Plomin; Kaili Rimfeld; Simon E Fisher; Beate St Pourcain
Journal:  Mol Psychiatry       Date:  2022-02-28       Impact factor: 13.437

7.  Anti-tumor activity of a novel proteasome inhibitor D395 against multiple myeloma and its lower cardiotoxicity compared with carfilzomib.

Authors:  Xuxing Shen; Chao Wu; Meng Lei; Qing Yan; Haoyang Zhang; Lina Zhang; Xueyuan Wang; Ye Yang; Jianyong Li; Yongqiang Zhu; Lijuan Chen
Journal:  Cell Death Dis       Date:  2021-04-30       Impact factor: 8.469

8.  A potential association of RNF219-AS1 with ADHD: Evidence from categorical analysis of clinical phenotypes and from quantitative exploration of executive function and white matter microstructure endophenotypes.

Authors:  Guang-Hui Fu; Wai Chen; Hai-Mei Li; Yu-Feng Wang; Lu Liu; Qiu-Jin Qian
Journal:  CNS Neurosci Ther       Date:  2021-02-28       Impact factor: 5.243

9.  TRIB2 modulates proteasome function to reduce ubiquitin stability and protect liver cancer cells against oxidative stress.

Authors:  Susu Guo; Yuxin Chen; Yueyue Yang; Xiao Zhang; Lifang Ma; Xiangfei Xue; Yongxia Qiao; Jiayi Wang
Journal:  Cell Death Dis       Date:  2021-01-07       Impact factor: 8.469

Review 10.  Progress on the Application of Bortezomib and Bortezomib-Based Nanoformulations.

Authors:  Jianhao Liu; Ruogang Zhao; Xiaowen Jiang; Zhaohuan Li; Bo Zhang
Journal:  Biomolecules       Date:  2021-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.